About primary HLH
Primary HLH: A hyperinflammatory condition of immune dysregulation1,2
Primary HLH is rapidly progressive and often fatal1
Primary hemophagocytic lymphohistiocytosis (HLH) is a rare, hyperinflammatory condition of immune dysregulation. It is characterized by interferon gamma (IFNγ)-activated macrophages that release an uncontrolled surge of proinflammatory cytokines.1,2 This surge is also known as the cytokine storm. The resulting hyperinflammation can quickly lead to organ damage and become life-threatening.3
Without timely diagnosis and effective treatment, the median survival for patients with primary HLH is under 2 months.1
Primary HLH can present in adulthood3-5
Primary HLH is increasingly recognized as a disease that can present across the lifespan.4 The threshold model provides a framework for understanding how inherited genetic susceptibility and hyperinflammatory burden may interact to influence when disease becomes clinically apparent.3,5
Individuals with genetic variants that partially impair cytolytic function or other genetic alterations that increase susceptibility to HLH may remain below the threshold for clinically apparent disease until a significant inflammatory trigger—such as infection, malignancy, or another immune challenge—pushes them above it.3,5
What influences when primary HLH becomes clinically apparent?
The threshold model of HLH is a framework for viewing the disease as a biological continuum. The model can be used to reflect how genetic susceptibility* and hyperinflammatory contributors may contribute to the manifestation of primary HLH.3,5
*Note that the genetic susceptibility that drives HLH can include innate and somatic genetic mutations.3,6
As a subtype, primary HLH can be visualized by placing examples along the continuum, based on individual patient presentation.3
Evidence of primary HLH in adults
In a retrospective review of 1,531 patients referred for genetic testing because of suspected HLH, investigators evaluated 175 adults (≥18 years) to determine whether mutations in HLH-associated genes were present. Adult patients underwent sequencing of PRF1, MUNC13-4, and STXBP2, with accompanying immunologic testing when available. Researchers assessed the prevalence and characteristics of HLH-associated mutations in adults presenting with suspected HLH.4
with suspected HLH (n=25) carried mutations in PRF1, MUNC13-4, or STXBP24
Adult-onset primary HLH occurred across a broad age range4
Most identified variants were hypomorphic, supporting partial cytotoxic dysfunction rather than complete loss of function4
While primary HLH is commonly associated with pediatric patients, genetic mutations associated with primary HLH may contribute to the development of the syndrome later in life following a significant inflammatory challenge.4
Early identification of primary HLH is critical but challenging1
Primary HLH may present with nonspecific clinical and laboratory signs, which often delay diagnosis.1
- Persistent high fever (>102°F [38.9°C], lasting ≥4 days)
- Infection
- Rash
- Hepatosplenomegaly
- Liver function impairment (eg, elevated liver enzymes)
- Hyperferritinemia
- Coagulation defects
- Severe cytopenia (affecting hemoglobin, platelets, and/or neutrophils)
- Seizures and central nervous system involvement
Recognize the pattern
A pattern of common clinical and laboratory findings can raise suspicion3:
FEVER
FERRITIN
FALLING BLOOD COUNTS
Consider these findings together and in the context of the patient's clinical presentation when evaluating for primary HLH.3
Many patients with primary HLH are admitted to the intensive care unit due to delays in diagnosis1
Collaboration between various specialists can help shorten the time it takes to identify this rare condition.7 These include:
- Emergency room physicians
- Immunologists
- Pathologists
- Clinical pharmacologists
- Rheumatologists
- Neurologists
- Hematologists
- Oncologists